ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
줄기세포 서비스 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 155억 6,000만 달러로 평가되었고, 2025년에는 172억 7,000만 달러에 달할 것으로 추정되며, CAGR 11.0%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 연구개발 투자 증가, 줄기세포 은행 서비스의 상업화 확대, 자동화 및 일회용 시스템 활용 증가, 생명공학 기업 및 제약 기업 간 제휴 확대, 줄기 세포 연구를 지원하는 관민 협력의 노력 증가와 관련이 있습니다.
줄기세포 서비스 시장 규모는 향후 수년간 급속한 성장이 예상되고 있습니다. 2029년에는 259억 4,000만 달러에 달할 것으로 예측되며, CAGR 10.7%로 성장이 전망되고 있습니다. 예측 기간의 성장은 헬스케어 인프라에 대한 투자 증가, 저침습 치료에 대한 수요 증가, 생명공학 기업과 연구기관 간의 연계 강화, 창약에서 줄기세포 이용 증가, 불임치료 및 생식의료에 대한 주목 증가에 의해 견인될 가능성이 있습니다. 예측 기간의 주요 동향은 자동화된 세포 처리 기술의 발전, 일회용 소모품 시스템의 발전, 개별화된 세포 치료의 혁신, 확장 가능한 생산 플랫폼의 개발, 데이터 구동 프로세스 최적화의 통합 등을 포함합니다.
맞춤형 치료에 대한 수요 증가는 향후 수년간 줄기세포 서비스 시장의 성장을 크게 견인할 것으로 예측됩니다. 맞춤형 치료는 효과를 극대화하고 부작용을 최소화하기 위해 개인의 유전자 구성, 생활 습관 및 특정 질병 특성에 맞게 조정된 의료 치료를 의미합니다. 이 맞춤형 의료로의 전환은 주로 유전자 검사 및 분자진단 기술의 진보에 의해 추진되고 있으며, 각 환자 고유의 생물학적 및 유전적 프로파일에 기초하여 치료를 커스터마이즈함으로써 치료 성과의 향상과 유해 작용의 저감을 실현합니다. 줄기세포 서비스는 환자별 줄기세포 및 맞춤형 재생 의료 솔루션을 제공함으로써 정밀하고 표적화된 치료 전략을 가능하게 하고 이 분야에서 매우 중요한 역할을 하고 있습니다. 예를 들어, 2024년 4월 퍼스널라이즈드 메디신 연합(PMC)이 발표한 보고서에 따르면, 미국 식품의약국(FDA)은 2024년 50개의 신규 분자 실체(NME)를 승인했으며, 그 중 18건(약 38%)이 맞춤형 의료로 분류되었습니다. 맞춤형 치료에 대한 수요 증가는 향후 줄기세포 서비스 시장의 성장을 계속 견인할 것으로 예측됩니다.
줄기세포 서비스 시장의 주요 기업은 공정 효율 향상, 오염 위험 감소, 엔드 투 엔드 세포 치료 제조의 간소화를 위해 단일 사용 소모품 시스템 등의 기술 혁신에 주력하고 있습니다. 단일 사용 소모품 시스템은 생물학적 물질과 접촉하는 장비를 단일 사용 설계로 사용하고 오염 위험을 최소화하면서 전반적인 생산 효율을 향상시키는 제조 기술을 말합니다. 예를 들어, 2025년 3월에는 스위스에 본사를 둔 생명 과학 도구 기업인 Limula SA가 세포 치료 제조의 복잡하고 단편화된 프로세스를 자동화하고 단일 원활한 워크플로우로 통합하도록 설계된 혁신적인 플랫폼인 LimONE을 발표했습니다. 이 시스템은 여러 단위 작업을 단일 폐쇄형 소모품에 통합하여 노동력, 장비 및 인프라 요구 사항을 줄이는 동시에 고도로 개별화된 세포 치료를 위한 공정 표준화, 확장성 및 보다 신속한 생산 일정을 보장합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 줄기세포 서비스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 줄기세포 서비스 시장 : 성장률 분석
세계의 줄기세포 서비스 시장 실적 : 규모 및 성장(2019-2024년)
세계의 줄기세포 서비스 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 줄기세포 서비스 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 줄기세포 서비스 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
맞춤형 서비스
줄기세포 분화
어세이 개발
스크리닝
기타 유형
세계의 줄기세포 서비스 시장 : 줄기세포 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
배아 줄기세포
성체 줄기세포
인공 다능성 줄기세포(IPS 세포)
세계의 줄기세포 서비스 시장 : 치료법 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
자가 줄기세포 치료
동종 줄기세포 치료
세계의 줄기세포 서비스 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
재생 의료
줄기세포 은행
세포 기반 분석
창약 및 개발
세계의 줄기세포 서비스 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
연구기관
제약기업
바이오테크놀러지 기업
세계의 줄기세포 서비스 시장 : 커스터마이즈 서비스 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
개별 프로토콜 설계
커스터마이즈 배양 조건
환자 특이적 세포 처리
맞춤 분석 보고서
세계의 줄기세포 서비스 시장 : 줄기세포 분화 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
간엽계 세포의 분화
신경계 분화
조혈계 세포의 분화
심장계 세포의 분화
세계의 줄기세포 서비스 시장 : 분석 개발 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
기능 분석 설계
세포 분석 최적화
바이오마커 분석 개발
높은 처리량 분석 설계
세계의 줄기세포 서비스 시장 : 스크리닝 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
저분자 스크리닝
창약 후보 스크리닝
유전자 편집 스크리닝
독성 스크리닝
세계의 줄기세포 서비스 시장 : 기타 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
셀 뱅크 서비스
품질 관리 시험
프로세스 개발 지원
바이오인포매틱스 해석
제7장 지역별 및 국가별 분석
세계의 줄기세포 서비스 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 줄기세포 서비스 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
줄기세포 서비스 시장 : 경쟁 구도
줄기세포 서비스 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
FUJIFILM Holdings Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Lonza Group AG : 개요, 제품 및 서비스, 전략 및 재무 분석
WuXi AppTec Co. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Charles River Laboratories International Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Miltenyi Biotec BV & Co. KG
AGC Biologics Inc.
GenScript Biotech Corporation
Vericel Corporation
LifeCell International Private Limited
Cryo-Cell International Inc.
Reelabs Private Limited
Medipost Co. Ltd.
Celltex Therapeutics Corporation
Kangstem Biotech Co. Ltd.
CellThera Ltd.
Anterogen Co. Ltd.
Healios KK
Sanpower Group Co. Ltd.
InoCells Co. Ltd.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
줄기세포 서비스 시장(2009년) : 새로운 기회를 제공하는 국가
줄기세포 서비스 시장(2009년) : 새로운 기회를 제공하는 부문
줄기세포 서비스 시장(2009년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Stem cell services refer to a broad range of medical and scientific offerings focused on the collection, processing, preservation, and application of stem cells for both therapeutic and research purposes. These services aim to ensure the availability of high-quality stem cells for use in regenerative medicine, disease treatment, and scientific advancement.
The key components of stem cell services include customized services, stem cell differentiation, assay development, screening, and other related types. Customized stem cell services provide tailored solutions designed to optimize stem cell handling, culture, differentiation, and analysis to meet specific research or therapeutic requirements. The various types of stem cells involved include embryonic stem cells, adult stem cells, and induced pluripotent stem cells (iPSCs). Therapy types include autologous stem cell therapy and allogeneic stem cell therapy. Applications span regenerative medicine, stem cell banking, cell-based assays, and drug discovery and development. Key end users include hospitals, research institutes, pharmaceutical companies, and biotechnology companies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The stem cell services market research report is one of a series of new reports from The Business Research Company that provides stem cell services market statistics, including stem cell services industry global market size, regional shares, competitors with a stem cell services market share, detailed stem cell services market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell services industry. This stem cell services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The stem cell services market size has grown rapidly in recent years. It will grow from $15.56 billion in 2024 to $17.27 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be linked to increasing investments in research and development, the expanding commercialization of stem cell banking services, rising use of automation and single-use systems, growing partnerships between biotech and pharmaceutical companies, and increasing public-private initiatives supporting stem cell research.
The stem cell services market size is expected to see rapid growth in the next few years. It will grow to $25.94 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be driven by rising investments in healthcare infrastructure, growing demand for minimally invasive treatments, expanding collaborations between biotech firms and research institutes, increasing utilization of stem cells in drug discovery, and a heightened focus on fertility and reproductive applications. Major trends in the forecast period include advancements in automated cell processing, progress in single-use consumable systems, innovations in personalized cell therapies, development of scalable production platforms, and the integration of data-driven process optimization.
The increasing demand for personalized therapies is expected to significantly drive the growth of the stem cell services market in the coming years. Personalized therapies involve medical treatments tailored to an individual's genetic makeup, lifestyle, and specific disease characteristics, with the goal of maximizing effectiveness and minimizing side effects. This shift towards personalized medicine is largely driven by advancements in genetic testing and molecular diagnostics, which allow treatments to be customized based on each patient's unique biological and genetic profile, improving therapeutic outcomes and reducing adverse effects. Stem cell services play a crucial role in this by providing patient-specific stem cells and customized regenerative solutions, enabling precise and targeted treatment strategies. For example, in April 2024, a report from the Personalized Medicine Coalition (PMC) highlighted that the U.S. Food and Drug Administration (FDA) approved 50 new molecular entities (NMEs) in 2024, 18 of which, or approximately 38%, were classified as personalized medicines. This growing demand for personalized therapies is expected to continue driving the expansion of the stem cell services market.
Leading companies in the stem cell services market are focusing on advancements such as single-use consumable systems to improve process efficiency, reduce contamination risks, and streamline end-to-end cell therapy manufacturing. Single-use consumable systems refer to a manufacturing approach where equipment that comes into contact with biological materials is designed for one-time use, minimizing contamination risks and improving overall production efficiency. For instance, in March 2025, Limula SA, a Switzerland-based life science tools company, launched LimONE, an innovative platform designed to automate and integrate the complex, fragmented processes of cell therapy manufacturing into a single seamless workflow. The system consolidates multiple unit operations into one closed consumable, reducing labor, equipment, and infrastructure requirements, while ensuring process standardization, scalability, and faster production timelines for highly personalized cell therapies.
In December 2024, Novo Holdings A/S, a Denmark-based investment and holding company, acquired Catalent, Inc. for an undisclosed amount. This acquisition allows Novo Holdings to enhance its position in the biopharmaceutical sector by expanding its strategic investments and collaborations. By leveraging Catalent's advanced development and manufacturing capabilities, Novo Holdings aims to accelerate the delivery of innovative therapies, including those in the stem cell services sector. Catalent, Inc. is a U.S.-based life sciences company that provides services for stem cell therapies.
Major companies operating in the stem cell services market are Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Miltenyi Biotec B.V. & Co. KG, AGC Biologics Inc., GenScript Biotech Corporation, Vericel Corporation, LifeCell International Private Limited, Cryo-Cell International Inc., Reelabs Private Limited, Medipost Co. Ltd., Celltex Therapeutics Corporation, Kangstem Biotech Co. Ltd., CellThera Ltd., Anterogen Co. Ltd., Healios K.K., Sanpower Group Co. Ltd., InoCells Co. Ltd.
North America was the largest region in the stem cell services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in stem cell services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the stem cell services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The stem cell services market includes revenues earned by entities by providing services such as stem cell line development services, clinical trial support services, training and educational services, stem cell therapy development services, and bioinformatics and data analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Stem Cell Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on stem cell services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for stem cell services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stem cell services market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Customize Service; Stem Cell Differentiation; Assay Development; Screening; Other Types
2) By Type Of Stem Cells: Embryonic Stem Cells; Adult Stem Cells; Induced Pluripotent Stem Cells (IPSCS)
3) By Assay Development: Functional Assay Design; Cellular Assay Optimization; Biomarker Assay Development; High Throughput Assay Design
3) By Screening: Small Molecule Screening; Drug Candidate Screening; Gene Editing Screening; Toxicity Screening
5) By Other Types: Cell Banking Services; Quality Control Testing; Process Development Support; Bioinformatics Analysis
Companies Mentioned: Thermo Fisher Scientific Inc.; FUJIFILM Holdings Corporation; Lonza Group AG; WuXi AppTec Co. Ltd.; Charles River Laboratories International Inc.; Miltenyi Biotec B.V. & Co. KG; AGC Biologics Inc.; GenScript Biotech Corporation; Vericel Corporation; LifeCell International Private Limited; Cryo-Cell International Inc.; Reelabs Private Limited; Medipost Co. Ltd.; Celltex Therapeutics Corporation; Kangstem Biotech Co. Ltd.; CellThera Ltd.; Anterogen Co. Ltd.; Healios K.K.; Sanpower Group Co. Ltd.; InoCells Co. Ltd.
Countries:
Table of Contents
1. Executive Summary
2. Stem Cell Services Market Characteristics
3. Stem Cell Services Market Trends And Strategies
4. Stem Cell Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Stem Cell Services Growth Analysis And Strategic Analysis Framework
5.1. Global Stem Cell Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Stem Cell Services Market Growth Rate Analysis
5.4. Global Stem Cell Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Stem Cell Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Stem Cell Services Total Addressable Market (TAM)
6. Stem Cell Services Market Segmentation
6.1. Global Stem Cell Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Customize Service
Stem Cell Differentiation
Assay Development
Screening
Other Types
6.2. Global Stem Cell Services Market, Segmentation By Type Of Stem Cells, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Embryonic Stem Cells
Adult Stem Cells
Induced Pluripotent Stem Cells (IPSCS)
6.3. Global Stem Cell Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous Stem Cell Therapy
Allogenic Stem Cell Therapy
6.4. Global Stem Cell Services Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Regenerative Medicine
Stem Cell Banking
Cell-Based Assays
Drug Discovery And Development
6.5. Global Stem Cell Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
6.6. Global Stem Cell Services Market, Sub-Segmentation Of Customize Service, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Personalized Protocol Design
Tailored Culture Conditions
Patient Specific Cell Processing
Custom Analytical Reporting
6.7. Global Stem Cell Services Market, Sub-Segmentation Of Stem Cell Differentiation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mesenchymal Lineage Differentiation
Neural Lineage Differentiation
Hematopoietic Lineage Differentiation
Cardiac Lineage Differentiation
6.8. Global Stem Cell Services Market, Sub-Segmentation Of Assay Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Functional Assay Design
Cellular Assay Optimization
Biomarker Assay Development
High Throughput Assay Design
6.9. Global Stem Cell Services Market, Sub-Segmentation Of Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Small Molecule Screening
Drug Candidate Screening
Gene Editing Screening
Toxicity Screening
6.10. Global Stem Cell Services Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cell Banking Services
Quality Control Testing
Process Development Support
Bioinformatics Analysis
7. Stem Cell Services Market Regional And Country Analysis
7.1. Global Stem Cell Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Stem Cell Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
